If you could vote on Brexit now which option would you choose?
   

Russian fund steps up production of anti-viral drug approved by Moscow for COVID-19


Russia’s sovereign wealth fund said on Thursday it will step up the production of the anti-viral drug Avifavir, an anti-influenza medicine which the Russian government has granted preliminary approval for treatment of COVID-19 patients. The Russian health ministry gave its approval for the drug’s use under a special accelerated process in May. Its Russian backers say it has shown a benefit in COVID-19 patients in early research. The first 100,000 treatment courses were delivered last month to 35 Russian regions, as well as to neighbouring Belarus, said the Russian Direct Investment Fund (RDIF) which has promoted the drug. RDIF said it was now set to produce more than 100,000 courses in July and that a joint venture with pharmaceutical firm ChemRar Group would allow it to increase production threefold to meet growing demand both domestically and internationally

Reuters - July 2, 2020

View the full story here: https://www.reuters.com/article/health-coronavirus-russia-flights/update-1-russian-fund-steps-up-production-of-anti-viral-drug-approved-by-moscow-for-covid-19-idUSL8N2E93EP